β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology

Alzheimer’s disease (AD) is a progressive, late-onset dementia with no effective treatment available. Recent studies suggest that AD pathology is driven by age-related changes in metabolism. Alterations in metabolism, such as placing patients on a ketogenic diet, can alter cognition by an unknown me...

Descripción completa

Detalles Bibliográficos
Autores principales: Shippy, Daniel C., Wilhelm, Connor, Viharkumar, Patel A., Raife, Thomas J., Ulland, Tyler K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507727/
https://www.ncbi.nlm.nih.gov/pubmed/32958021
http://dx.doi.org/10.1186/s12974-020-01948-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507727/
https://www.ncbi.nlm.nih.gov/pubmed/32958021
http://dx.doi.org/10.1186/s12974-020-01948-5

Ejemplares similares